跳至主要内容
临床试验/RPCEC00000198
RPCEC00000198招募中4 期

Evaluation of the safety and effectiveness of SURFACEN, in combination with conventional therapy in the treatment of acute respiratory distress syndrome in adults. National extension.

ational Centre of Animal and Plants Health (CENSA)0 个研究点目标入组 184 人开始时间: 2015年6月24日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
184

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment

入排标准

年龄范围
18 years 至 one(—)
性别
All

入选标准

  • 1. Diagnosis of ARDS, according to the new definition of ARDS Berlin
  • 2. Patient or member family frontline which expresses voluntariness written entering the study by signing the informed voluntary consent
  • 3. 18 years and older.

排除标准

  • 1. Pregnant and postpartum women
  • 2. Chronic obstructive pulmonary disease (COPD).
  • 3. Patient at the time of inclusion is receiving other investigational drug.
  • 4. Prior knowledge of a known allergy or sensitivity to SURFACEN® or any component of the formulation.

研究者

发起方
ational Centre of Animal and Plants Health (CENSA)

相似试验

SURFACEN in ARDS. Adults. Phase IV | 临床试验